Company Directory - Research & Development
We are creating new treatments to reverse the progression of disease, improve quality of life, and inform clinical decisions. We are building prescription digital therapeutics that deliver a new kind of behavioral therapy, and creating feedback mechanisms using remotely-monitored and patient-generated data.
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us.
BioMed X is an independent research institute located at the campus environment of the University of Heidelberg in Southern Germany. We operate at the interface between academia and industry and perform biomedical preclinical research projects in the fields of biomedicine, molecular biology, cell biology and diagnostics.
Antimicrobial Resistance (AMR) is the silent pandemic that threatens our global healthcare systems and well-being in an unprecedented manner. At BioVersys, we fight AMR using innovation to save lives and improve patient outcomes.
Biofidelity’s mission is to provide access to precision cancer diagnostics for all patients. Our breakthrough ASPYRE technology delivers ultra-sensitive, comprehensive results quickly and affordably, enabling clinicians to make fast, well-informed treatment decisions for their patients.
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Bioniz Therapeutics is a clinical-stage biopharmaceutical company leading the discovery and development of first-in-class multi-cytokine inhibitory peptide therapeutics to address immuno-inflammatory diseases and cancer.
Black Diamond Therapeutics: A Precision Oncology Medicine Company Pioneering the Discovery of Small Molecule, MasterKey Therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist.
At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it.
Bolt is pioneering a new category of targeted immunotherapies that leverage the precision of antibody targeting with the activation of the innate and adaptive immune systems in the tumor microenvironment. Bolt is a world-class, inclusive community of fearless innovators committed to delivering transformative treatments to cancer patients with unmet medical needs.
Bone Therapeutics is a leading cell therapy company addressing high unmet medical needs in the field of orthopaedics and bone diseases. We have a broad, diversified portfolio of bone cell therapy solutions and viscosupplement in clinical development across a number of disease areas targeting markets with large unmet medical needs and limited innovation.
Breakpoint Therapeutics is a newly founded company that will discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways.
BridgeBio ultimately exists to help patients. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap.
Bruker's differentiated high-value life science research and diagnostics solutions enable scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.
CSL Behring has grown into a global biotechnology leader, driven by the promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first.
A first-of-its-kind therapeutics company that is discovering and developing medicines by studying and altering cell behaviors. Cellarity has developed a powerful, generalizable platform harnessing single-cell technologies and machine learning to unveil the network state of a given cell, defining the cell's behavior.
